A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori

Publisher： Karger

E-ISSN： 1421-9867|94|4|240-246

ISSN： 0012-2823

Source： Digestion, Vol.94, Iss.4, 2016-12, pp. : 240-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Gastric Cancer by Helicobacter pylori Eradication

By  

Digestive Diseases, Vol. 22, Iss. 4, 2005-03 ,pp. : 313-319

Karger

Access to resources Recommend Favorite

Prevention of Gastric Cancer by Helicobacter pylori Eradication?

By  

Digestive Diseases, Vol. 20, Iss. 1, 2002-07 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Gastric Cancer Development after Helicobacter pylori Eradication Therapy: A New Form of Gastric Neoplasia

By  

Digestion, Vol. 85, Iss. 1, 2012-01 ,pp. : 61-67

Karger

Access to resources Recommend Favorite

Healing Effects of Rebamipide and Omeprazole in Helicobacter pylori-Positive Gastric Ulcer Patients after Eradication Therapy: A Randomized Double-Blind, Multinational, Multi-Institutional Comparative Study

By  

Digestion, Vol. 84, Iss. 3, 2011-07 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study

By Befrits R.   Sjöstedt S.   Tour R.   Leijonmarck C.-E.   Hedenborg L.   Backman M.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1066-1072

Informa Healthcare

Access to resources Recommend Favorite